Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F.

COVID-19 spreads from an infected person to others through respiratory droplets and aerosols that can vary in size, such as: large droplets that fall to the ground rapidly (within seconds or minutes) ...

The FDC tablet reduces the daily pill count from four to two tablets ... disease presentations and a reduction in hospitalizations due to COVID-19 related severe respiratory disease, pose significant ...

Raining on the parade even more, Pfizer just reported some good news that seems to confirm the presence of some internal ...

The wide-ranging rally came after US drugmaker Pfizer's announcement of a new experimental antiviral pill to treat COVID-19. Pfizer was up 7.9% after it claimed its new drug would cut the risk of ...

(Reuters) -Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on Tuesday that the drugmaker's turnaround is succeeding after it reported a ...

The stock of Pfizer (PFE) is up about 2% after the pharmaceutical company issued third-quarter financial results that beat Wall Street forecasts and raised its forward guidance. Pfizer reported ...

Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year ...

Sales of key drugs Xeljanz and Ibrance declined in the quarter. Pfizer's COVID revenues include direct sales and alliance ...

Pfizer reported an earnings beat Tuesday morning and raised its full-year outlook, seeing strength in sales of its Covid ...

COVID depression is a term used to describe a common issue some people experience after a COVID infection or as part of long COVID—sometimes referred to as PASC (post-acute sequelae of COVID-19).

TOKYO (Reuters) - Japan's Shionogi & Co said on Tuesday a global, late-stage study showed its pill-based treatment for COVID-19 was effective in reducing transmission of the disease. Ensitrelvir, ...